Dr Antony Rix

Lucida Medical Ltd

Position: Head of Department
Personal home page: https://lucidamedical.com
Email:   enquiries@lucidamedical.com

PubMed journal articles - click here

Research description

Co-founded by Prof Evis Sala and Dr Antony Rix, Lucida Medical is a spin-out from the University of Cambridge Department of Radiology and Cambridge University Hospitals. The company develops AI-based software to help automate the analysis of oncological imaging, to make cancer screening, diagnosis and treatment faster, more accurate and effective.

Lucida Medical has recently announced a substantial investment led by XTX Ventures and Prostate Cancer Research - for more details see https://lucidamedical.com/2021-cambridge-ai-startup-prostate-cancer-inve...

Research Programme
Early Cancer Institute
Secondary Programme
Advanced Cancer Imaging
Methods and technologies
Clinical practice
Clinical trials
Genomics
Imaging
Immunohistochemistry
Magnetic Resonance Imaging (MRI)
Tumour type interests
Prostate
Keywords
Prostate cancer diagnosis
artificial intelligence (AI)
machine learning (ML)
magnetic resonance imaging (MRI)

Key publications

J Suchanek, AW Rix, AH Mehan, CJL Doran, AR Padhani, C Kastner, T Barrett, E Sala, Multi-stage AI analysis system to support prostate cancer diagnostic imaging. EuSoMII Virtual Annual Meeting, 24 October 2020. Paper available at https://lucidamedical.com/wp-content/uploads/2020/12/Suchanek-J-et-al.-M...

Example outputs of prostate cancer AI prototype, patients with biopsy-verified Gleason Grade Group 2+ prostate cancer.